![](https://startllc.com/wp-content/uploads/2024/01/Neuralace-300x165.jpg)
FDA clears painful diabetic neuropathy neurostim therapy from Neuralace
Neuralace Medical announced today that it received FDA clearance for its chronic painful diabetic neuropathy (PDN) treatment.
Neuralace Medical announced today that it received FDA clearance for its chronic painful diabetic neuropathy (PDN) treatment.
Zeta Surgical announced today that the FDA granted it a special 510(k) clearance for expanded software functionality.